Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Dissecting human disease with single-cell omics: application in model systems and in the clinic.

Strzelecka PM, Ranzoni AM, Cvejic A.

Dis Model Mech. 2018 Nov 5;11(11). pii: dmm036525. doi: 10.1242/dmm.036525. Review.


Single-cell biology: resolving biological complexity, one cell at a time.

Ranzoni AM, Cvejic A.

Development. 2018 Jul 9;145(13). pii: dev163972. doi: 10.1242/dev.163972. Review.


Micro-computed tomography reconstructions of tibiae of stem cell transplanted osteogenesis imperfecta mice.

Ranzoni AM, Corcelli M, Arnett TR, Guillot PV.

Sci Data. 2018 May 29;5:180100. doi: 10.1038/sdata.2018.100.


Embryonic Stem Cell-Derived Mesenchymal Stem Cells (MSCs) Have a Superior Neuroprotective Capacity Over Fetal MSCs in the Hypoxic-Ischemic Mouse Brain.

Hawkins KE, Corcelli M, Dowding K, Ranzoni AM, Vlahova F, Hau KL, Hunjan A, Peebles D, Gressens P, Hagberg H, de Coppi P, Hristova M, Guillot PV.

Stem Cells Transl Med. 2018 May;7(5):439-449. doi: 10.1002/sctm.17-0260. Epub 2018 Feb 28.


TGFβ-induced osteogenic potential of human amniotic fluid stem cells via CD73-generated adenosine production.

Hau KL, Ranzoni AM, Vlahova F, Hawkins K, De Coppi P, David AL, Guillot PV.

Sci Rep. 2017 Jul 26;7(1):6601. doi: 10.1038/s41598-017-06780-1.


Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.

Hawkins KE, Moschidou D, Faccenda D, Wruck W, Martin-Trujillo A, Hau KL, Ranzoni AM, Sanchez-Freire V, Tommasini F, Eaton S, De Coppi P, Monk D, Campanella M, Thrasher AJ, Adjaye J, Guillot PV.

Mol Ther. 2017 Feb 1;25(2):427-442. doi: 10.1016/j.ymthe.2016.11.014.


Counteracting bone fragility with human amniotic mesenchymal stem cells.

Ranzoni AM, Corcelli M, Hau KL, Kerns JG, Vanleene M, Shefelbine S, Jones GN, Moschidou D, Dala-Ali B, Goodship AE, De Coppi P, Arnett TR, Guillot PV.

Sci Rep. 2016 Dec 20;6:39656. doi: 10.1038/srep39656.

Supplemental Content

Loading ...
Support Center